Cargando…
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
BACKGROUND: Data regarding CD4+ recovery after switching from protease inhibitor (PI)-based regimens to regimens not containing PI are scarce. METHODS: Subjects with virological success on first-PI-regimens who switched to NNRTI therapy (NNRTI group) or to nucleoside reverse transcriptase (NRTI)-onl...
Autores principales: | Torti, Carlo, d'Arminio-Monforte, Antonella, Pozniak, Anton L, Lapadula, Giuseppe, Cologni, Giuliana, Antinori, Andrea, De Luca, Andrea, Mussini, Cristina, Castagna, Antonella, Cicconi, Paola, Minoli, Lorenzo, Costantini, Andrea, Carosi, Giampiero, Liang, Hua, Cesana, Bruno M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038912/ https://www.ncbi.nlm.nih.gov/pubmed/21266068 http://dx.doi.org/10.1186/1471-2334-11-23 |
Ejemplares similares
-
Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen
por: Aragão, F, et al.
Publicado: (2010) -
The state of PI monotherapy and NRTI-sparing therapy
por: Arribas, JR
Publicado: (2010) -
The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI
por: Liu, Shengnan, et al.
Publicado: (2023) -
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data
por: Sangaré, Mohamed N’dongo, et al.
Publicado: (2020) -
HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting
por: Garagiola, Elisabetta, et al.
Publicado: (2020)